Question-and-Answer Session
Operator
(Operator Instructions). Your first question comes from the line of Bert Hazlett from BMO Capital Markets.
Jim Tumbering - BMO Capital Markets
It’s Jim Tumbering with Bert. Two questions. First, maybe if you could just quantify the financial benefit going forward of some of the additional restructuring efforts. And then secondly, you booked in one milestone payment from Otsuka. You have several other deals with them. Can we expect any other milestone payment from in the future? Thanks.
Jennifer Good
So the financial benefits, there are sort of two things in the $3 million. There is about $2 million that will be sort of a recurring annualized amount from salaries and benefits and also facility savings. The extra $1 million was things that were in the plan that we've removed and your second question on can you expect to see further Otsuka development milestones there, so this milestone that we earn was on our first agreement Otsuka, you probably know Jim we have three different deals with Otsuka. So this is on the first one. This was actually the first eligible milestone. It was an important one and having hit that target we are eligible for not only additional milestone under first agreement but we have significant amount of work going on, on both agreements two and three. So, I would hope so.
Jim Tumbering - BMO Capital Markets
Any further clarity you can give us on timing of those or too early to tell?
Jennifer Good
It's too early to tell because it really becomes up to Otsuka how they prioritize these and move them ahead and also there are discussion about giving timeline guidance. So I don't have any additional guidance.
Operator
Your next question comes from the line of David Watson, Individual Investor.
David Watson
I am wondering if you have any update on the patent extensions. I know in the last call you talked about the likely decision would be this quarter, so I don't know the quarter is sort of half way done I don't know if you have any insight into that?
Jennifer Good
There are two big buckets of patents. Patents we're prosecuting and patents Endo is prosecuting. The patents Endo is prosecuting, many of them have been put up for appeal which is all available on the PTO website. They are in different buckets, so there will be several different appeals heard. The first bucket of appeals of these patents includes about four different patents which were un-expedited review. The timing has been firmed up about oral arguments which will be heard this quarter. We now expect or Endo expect the decision likely in the first quarter of next year.
- To read the full transcript on Seeking Alpha, click here »
